CN112204139A - 用于从样品中的一种或多种类型的微生物的不同群体中提取核酸分子的通用方法 - Google Patents
用于从样品中的一种或多种类型的微生物的不同群体中提取核酸分子的通用方法 Download PDFInfo
- Publication number
- CN112204139A CN112204139A CN201980036347.2A CN201980036347A CN112204139A CN 112204139 A CN112204139 A CN 112204139A CN 201980036347 A CN201980036347 A CN 201980036347A CN 112204139 A CN112204139 A CN 112204139A
- Authority
- CN
- China
- Prior art keywords
- sample
- subject
- genetic material
- microbiome
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 119
- 108020004707 nucleic acids Proteins 0.000 title abstract description 44
- 102000039446 nucleic acids Human genes 0.000 title abstract description 44
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 44
- 238000007429 general method Methods 0.000 title description 5
- 238000000034 method Methods 0.000 claims abstract description 96
- 239000006041 probiotic Substances 0.000 claims abstract description 56
- 235000018291 probiotics Nutrition 0.000 claims abstract description 56
- 238000004458 analytical method Methods 0.000 claims abstract description 54
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 52
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 49
- 230000000529 probiotic effect Effects 0.000 claims abstract description 44
- 238000012163 sequencing technique Methods 0.000 claims abstract description 31
- 235000005911 diet Nutrition 0.000 claims abstract description 17
- 230000000378 dietary effect Effects 0.000 claims abstract description 4
- 230000009089 cytolysis Effects 0.000 claims description 69
- 239000000203 mixture Substances 0.000 claims description 51
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 29
- 235000013305 food Nutrition 0.000 claims description 27
- 239000011324 bead Substances 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 15
- 241000894007 species Species 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 230000000813 microbial effect Effects 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 230000003196 chaotropic effect Effects 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000003599 detergent Substances 0.000 claims description 12
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 claims description 11
- 235000012631 food intake Nutrition 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 230000002538 fungal effect Effects 0.000 claims description 8
- 230000000968 intestinal effect Effects 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 208000027244 Dysbiosis Diseases 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- 230000007140 dysbiosis Effects 0.000 claims description 6
- 230000002550 fecal effect Effects 0.000 claims description 6
- 235000021073 macronutrients Nutrition 0.000 claims description 6
- 235000013406 prebiotics Nutrition 0.000 claims description 6
- 210000004215 spore Anatomy 0.000 claims description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 230000007613 environmental effect Effects 0.000 claims description 5
- 230000035784 germination Effects 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002705 metabolomic analysis Methods 0.000 claims description 5
- 230000001431 metabolomic effect Effects 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 4
- 238000000527 sonication Methods 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 210000004666 bacterial spore Anatomy 0.000 claims description 3
- 238000002635 electroconvulsive therapy Methods 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- -1 chemotherapy Substances 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 238000007781 pre-processing Methods 0.000 claims description 2
- 238000007619 statistical method Methods 0.000 claims description 2
- 206010022657 Intestinal infarction Diseases 0.000 claims 1
- 238000010296 bead milling Methods 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000003801 milling Methods 0.000 claims 1
- 230000001151 other effect Effects 0.000 claims 1
- 230000035882 stress Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 17
- 241000700605 Viruses Species 0.000 abstract description 16
- 241000233866 Fungi Species 0.000 abstract description 12
- 238000000605 extraction Methods 0.000 abstract description 11
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 241001515965 unidentified phage Species 0.000 abstract description 7
- 241000203069 Archaea Species 0.000 abstract description 6
- 241000235070 Saccharomyces Species 0.000 abstract description 5
- 241000283690 Bos taurus Species 0.000 abstract description 4
- 241000206602 Eukaryota Species 0.000 abstract description 4
- 210000004102 animal cell Anatomy 0.000 abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 abstract description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract description 2
- 238000011529 RT qPCR Methods 0.000 abstract description 2
- 244000045947 parasite Species 0.000 abstract description 2
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 abstract 1
- 238000007844 allele-specific PCR Methods 0.000 abstract 1
- 244000000013 helminth Species 0.000 abstract 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 87
- 239000000243 solution Substances 0.000 description 64
- 241000282412 Homo Species 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 238000010586 diagram Methods 0.000 description 16
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 15
- 230000037213 diet Effects 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- 210000002421 cell wall Anatomy 0.000 description 12
- 244000005709 gut microbiome Species 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 108010067770 Endopeptidase K Proteins 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 229960000789 guanidine hydrochloride Drugs 0.000 description 8
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241000192125 Firmicutes Species 0.000 description 6
- 102000016943 Muramidase Human genes 0.000 description 6
- 108010014251 Muramidase Proteins 0.000 description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229960000274 lysozyme Drugs 0.000 description 6
- 239000004325 lysozyme Substances 0.000 description 6
- 235000010335 lysozyme Nutrition 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 241001134770 Bifidobacterium animalis Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 229940118852 bifidobacterium animalis Drugs 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000186146 Brevibacterium Species 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000003066 decision tree Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000011331 genomic analysis Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 235000019724 non-vegetarian diet Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 235000003563 vegetarian diet Nutrition 0.000 description 4
- 241000589291 Acinetobacter Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 241000186604 Lactobacillus reuteri Species 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000013473 artificial intelligence Methods 0.000 description 3
- 238000010009 beating Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003862 health status Effects 0.000 description 3
- 229940001882 lactobacillus reuteri Drugs 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000013515 script Methods 0.000 description 3
- 210000001138 tear Anatomy 0.000 description 3
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000425347 Phyla <beetle> Species 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- BFDMCHRDSYTOLE-UHFFFAOYSA-N SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 Chemical compound SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 BFDMCHRDSYTOLE-UHFFFAOYSA-N 0.000 description 2
- 241001123227 Saccharomyces pastorianus Species 0.000 description 2
- 241000221662 Sclerotinia Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000007366 host health Effects 0.000 description 2
- 244000005702 human microbiome Species 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 238000012966 insertion method Methods 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000003050 macronutrient Effects 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 244000039328 opportunistic pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037221 weight management Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000701844 Bacillus virus phi29 Species 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000078137 Burkholderia virus BcepMu Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000244160 Echinococcus Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000224431 Entamoeba Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241001002751 Enterobacteria phage cdtI Species 0.000 description 1
- 241000943515 Enterococcus phage phiFL4A Species 0.000 description 1
- 241000725578 Equid gammaherpesvirus 2 Species 0.000 description 1
- 241000860043 Escherichia phage HK639 Species 0.000 description 1
- 241000702055 Escherichia virus HK022 Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241000499376 Lactobacillus phage A2 Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 230000021839 RNA stabilization Effects 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000700141 Rotifera Species 0.000 description 1
- 241000198063 Saccharomyces kudriavzevii Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 238000007847 digital PCR Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000008528 macronutrient intake Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/125—Specific component of sample, medium or buffer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/137—Concentration of a component of medium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862651620P | 2018-04-02 | 2018-04-02 | |
| US62/651,620 | 2018-04-02 | ||
| PCT/US2019/025457 WO2019195342A1 (en) | 2018-04-02 | 2019-04-02 | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112204139A true CN112204139A (zh) | 2021-01-08 |
Family
ID=68101118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980036347.2A Pending CN112204139A (zh) | 2018-04-02 | 2019-04-02 | 用于从样品中的一种或多种类型的微生物的不同群体中提取核酸分子的通用方法 |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP2021520191A (ko) |
| KR (1) | KR20200140303A (ko) |
| CN (1) | CN112204139A (ko) |
| AU (1) | AU2019247693A1 (ko) |
| CA (1) | CA3095745A1 (ko) |
| GB (1) | GB2587545B (ko) |
| IL (1) | IL277682A (ko) |
| SG (1) | SG11202009744WA (ko) |
| WO (1) | WO2019195342A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113186185B (zh) * | 2020-01-14 | 2023-05-26 | 东北林业大学 | 一种从哺乳动物粪便中高效富集宿主dna的方法 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002541824A (ja) * | 1999-04-09 | 2002-12-10 | エグザクト サイエンシーズ コーポレイション | 癌の指標である核酸を検出するための方法 |
| KR20050103085A (ko) * | 2004-04-24 | 2005-10-27 | 한국생명공학연구원 | 유산균을 검출하기 위한 게놈 마이크로어레이 및 이를이용한 유산균의 검출 방법 |
| WO2012043183A1 (ja) * | 2010-09-28 | 2012-04-05 | オリンパス株式会社 | 糞便中の標的核酸の合成方法 |
| US20130338350A1 (en) * | 2012-06-15 | 2013-12-19 | Ut-Battelle, Llc | Method for isolating nucleic acids |
| CN105518150A (zh) * | 2013-09-06 | 2016-04-20 | 索发股份公司 | 用于评价包含微生物的组合物对肠道微生物群的作用的方法 |
| US20160110515A1 (en) * | 2014-10-21 | 2016-04-21 | Zachary Apte | Method and system for microbiome-derived diagnostics and therapeutics |
| CN106460048A (zh) * | 2014-04-28 | 2017-02-22 | 耶达研究及发展有限公司 | 针对试剂的微生物组应答 |
| WO2018053308A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics Llc | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US20180080065A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU91864B1 (en) * | 2011-09-02 | 2013-03-04 | Univ Luxembourg | Method and kit for the isolation of genomic DNA, RNA, proteins and metabolites from a single biological sample |
| US20150225712A1 (en) * | 2012-08-21 | 2015-08-13 | Qiagen Gmbh | Method for isolating nucleic acids from a formaldehyde releaser stabilized sample |
| US11773455B2 (en) * | 2015-09-09 | 2023-10-03 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage |
| WO2017070123A1 (en) * | 2015-10-19 | 2017-04-27 | Dovetail Genomics, Llc | Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection |
-
2019
- 2019-04-02 CA CA3095745A patent/CA3095745A1/en active Pending
- 2019-04-02 SG SG11202009744WA patent/SG11202009744WA/en unknown
- 2019-04-02 JP JP2020553639A patent/JP2021520191A/ja active Pending
- 2019-04-02 CN CN201980036347.2A patent/CN112204139A/zh active Pending
- 2019-04-02 KR KR1020207031144A patent/KR20200140303A/ko not_active Application Discontinuation
- 2019-04-02 AU AU2019247693A patent/AU2019247693A1/en active Pending
- 2019-04-02 WO PCT/US2019/025457 patent/WO2019195342A1/en unknown
- 2019-04-02 GB GB2017361.3A patent/GB2587545B/en active Active
-
2020
- 2020-09-30 IL IL277682A patent/IL277682A/en unknown
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002541824A (ja) * | 1999-04-09 | 2002-12-10 | エグザクト サイエンシーズ コーポレイション | 癌の指標である核酸を検出するための方法 |
| KR20050103085A (ko) * | 2004-04-24 | 2005-10-27 | 한국생명공학연구원 | 유산균을 검출하기 위한 게놈 마이크로어레이 및 이를이용한 유산균의 검출 방법 |
| WO2012043183A1 (ja) * | 2010-09-28 | 2012-04-05 | オリンパス株式会社 | 糞便中の標的核酸の合成方法 |
| US20130338350A1 (en) * | 2012-06-15 | 2013-12-19 | Ut-Battelle, Llc | Method for isolating nucleic acids |
| CN105518150A (zh) * | 2013-09-06 | 2016-04-20 | 索发股份公司 | 用于评价包含微生物的组合物对肠道微生物群的作用的方法 |
| CN106460048A (zh) * | 2014-04-28 | 2017-02-22 | 耶达研究及发展有限公司 | 针对试剂的微生物组应答 |
| US20160110515A1 (en) * | 2014-10-21 | 2016-04-21 | Zachary Apte | Method and system for microbiome-derived diagnostics and therapeutics |
| WO2018053308A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics Llc | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US20180080065A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
Non-Patent Citations (2)
| Title |
|---|
| LYNNETTE R. FERGUSON等: "The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies", MOLECULAR NUTRITION & FOOD RESEARCH, vol. 60, no. 1, 7 August 2015 (2015-08-07), pages 119 - 133 * |
| 松木吏弓: "DNA鑑定を利用した野生動物調査法を開発", pages 4, Retrieved from the Internet <URL:https://criepi.denken.or.jp/koho/news/den441.pdf> * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2587545B (en) | 2023-06-14 |
| GB2587545A (en) | 2021-03-31 |
| AU2019247693A1 (en) | 2020-11-19 |
| CA3095745A1 (en) | 2019-10-10 |
| WO2019195342A1 (en) | 2019-10-10 |
| SG11202009744WA (en) | 2020-10-29 |
| KR20200140303A (ko) | 2020-12-15 |
| IL277682A (en) | 2020-11-30 |
| EP3775197A1 (en) | 2021-02-17 |
| GB202017361D0 (en) | 2020-12-16 |
| JP2021520191A (ja) | 2021-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10428370B2 (en) | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample | |
| Kokou et al. | Host genetic selection for cold tolerance shapes microbiome composition and modulates its response to temperature | |
| Voigt et al. | Temporal and technical variability of human gut metagenomes | |
| Lima et al. | Prepartum and postpartum rumen fluid microbiomes: characterization and correlation with production traits in dairy cows | |
| Pitta et al. | Metagenomic assessment of the functional potential of the rumen microbiome in Holstein dairy cows | |
| Ross et al. | Investigating the effect of two methane-mitigating diets on the rumen microbiome using massively parallel sequencing | |
| Pitta et al. | Bacterial diversity associated with feeding dry forage at different dietary concentrations in the rumen contents of Mehshana buffalo (Bubalus bubalis) using 16S pyrotags | |
| AU2017328927B2 (en) | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample | |
| CN114144387A (zh) | 用于从微生物的不同群体中提取核酸分子的通用方法 | |
| Highlander | High throughput sequencing methods for microbiome profiling: application to food animal systems | |
| Azad et al. | Characterization of the rumen and fecal microbiome in bloated and non-bloated cattle grazing alfalfa pastures and subjected to bloat prevention strategies | |
| Amin et al. | Metagenomic profiles of core and signature bacteria in the guts of white shrimp, Litopenaeus vannamei, with different growth rates | |
| Park et al. | The rumen liquid metatranscriptome of post-weaned dairy calves differed by pre-weaning ruminal administration of differentially-enriched, rumen-derived inocula | |
| CN112204139A (zh) | 用于从样品中的一种或多种类型的微生物的不同群体中提取核酸分子的通用方法 | |
| US11959125B2 (en) | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample | |
| Jiao et al. | Transcriptome landscape of intracellular Brucella ovis surviving in RAW264. 7 macrophage immune system | |
| Olson et al. | Application of microbial analyses to feeds and potential implications for poultry nutrition | |
| JP2024063020A (ja) | 試料中の１つ以上の種類の微生物の多様な集団から核酸分子を抽出するための万能な方法 | |
| Fehlner-Peach et al. | Distinct polysaccharide growth profiles of human intestinal Prevotella copri isolates | |
| Yang et al. | An ancient deletion in the ABO gene affects the composition of the porcine microbiome by altering intestinal N-acetyl-galactosamine concentrations | |
| Wu et al. | A compendium of ruminant gastrointestinal phage genomes revealed a higher proportion of lytic phages than in any other environments | |
| KUSONMANO | High-resolution study of fecal microbiome in Thai captive elephants towards nutrition management and welfare improvement | |
| EP4363603A1 (en) | Systems and methods for identifying microbial signatures | |
| Casu Pereira de Sousa | Comparing processed and raw honey microbiota using 16S gene barcoding | |
| Older et al. | Evaluating nanopore sequencing for microbial community characterization in catfish pond water |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |